Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)
Title:
Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)
Author:
Ford, Janet Tassorelli, Cristina Leroux, Elizabeth Wang, Shufang Ayer, David Nichols, Russell Detke, Holland